Skip to main content
An official website of the United States government

yttrium Y 90 ibritumomab tiuxetan

A radioimmunotherapeutic agent consisting of a murine monoclonal anti-CD20 antibody (ibritumomab) linked by the chelator tiuxetan to the radioisotope yttrium-90 (Y 90). Yttrium Y 90 ibritumomab tiuxetan binds to and specifically delivers beta radiation to CD20-expressing tumor cells, thereby minimizing the systemic effects of radiation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:90Y ibritumomab tiuxetan
IDEC-Y2B8 monoclonal antibody
Y90 Zevalin
Code name:IDEC Y2B8
NSC code:710085
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search